RHO6.F
Roche Holding AG
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
48.53
▼ 0.88 (1.78%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
48.53
Prev close
49.41
Day high
48.53
Day low
48.53
Volume
280
Market cap
$309.34B
P/E (TTM)
23.67
52W range
33.49 – 50.95
Day trading desk
Gap from prior close
-1.78%
Prior close 49.41
VWAP
48.53
0.00% from price
Relative volume
9.33×
Unusually busy
Session range
—
48.53 – 48.53
Position in range
—
—
ATR (14D)
0.67
1.38% of price
Prior day high
49.43
PDH
Prior day low
49.41
PDL
Bid / ask spread
—
Quote not published
Session volume
280
Avg 30
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.93%
+3.3%
1M
+8.69%
+5.0%
3M
+5.50%
+2.4%
6M
-2.27%
-13.3%
YTD
+10.80%
-1.5%
1Y
+40.42%
+20.4%
3Y
+44.43%
-29.7%
5Y
+23.82%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on RHO6.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
0
Total on file
Fundamentals
Market cap$309.34B
Enterprise value$336.93B
Revenue (TTM)$62.96B
Gross profit$46.69B
EBITDA$23.96B
Net income$12.34B
EPS (TTM)$2.05
Free cash flow$10.32B
Total cash$9.73B
Total debt$33.31B
Book value / share$5.51
Shares outstanding5.52B
Float5.23B
Short % of float—
Dividend yield2.72%
Beta (5Y)0.35
Valuation & profitability ratios
Trailing P/E23.67
Forward P/E—
PEG ratio1.63
Price / sales—
Price / book8.81
EV / revenue5.35
EV / EBITDA14.06
Gross margin74.17%
Operating margin36.20%
Profit margin19.60%
Return on equity38.11%
Return on assets13.51%
Debt / equity90.72
Current ratio1.23
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $63.36B | $62.40B | $60.44B | $65.81B | +1.5% |
| Operating revenue | $63.36B | $62.40B | $60.44B | $65.81B | +1.5% |
| Cost of revenue | $16.64B | $16.28B | $16.36B | $19.74B | +2.2% |
| Gross profit | $46.71B | $46.11B | $44.08B | $46.08B | +1.3% |
| Research & development | $13.35B | $15.30B | $14.20B | $15.22B | -12.8% |
| Selling, general & admin | $15.16B | $14.90B | $14.88B | $14.20B | +1.8% |
| Total operating expense | $28.23B | $32.70B | $28.69B | $28.60B | -13.6% |
| Operating income | $18.48B | $13.42B | $15.39B | $17.48B | +37.7% |
| Net interest income | -$1.14B | -$1.15B | -$814.00M | -$673.00M | +1.4% |
| Pre-tax income | $16.97B | $11.79B | $14.08B | $16.33B | +43.9% |
| Tax provision | $3.17B | $2.61B | $1.72B | $2.80B | +21.8% |
| Net income | $12.88B | $8.28B | $11.50B | $12.42B | +55.6% |
| Net income to common | $12.88B | $8.28B | $11.50B | $12.42B | +55.6% |
| Basic EPS | 2.02 | 1.30 | 1.80 | 1.94 | +55.7% |
| Diluted EPS | 2.01 | 1.29 | 1.79 | 1.92 | +55.6% |
| EBIT | $18.32B | $13.20B | $15.08B | $17.02B | +38.8% |
| EBITDA | $21.70B | $16.62B | $18.54B | $20.86B | +30.6% |
| Basic shares | 6.37B | 6.38B | 6.39B | 6.40B | -0.1% |
| Diluted shares | 6.42B | 6.42B | 6.43B | 6.46B | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $5.58B | $6.97B | $5.38B | $4.99B | -20.0% |
| Cash & short-term investments | $15.48B | $17.32B | $10.51B | $9.77B | -10.6% |
| Accounts receivable | $12.39B | $12.01B | $11.64B | $12.12B | +3.2% |
| Inventory | $7.48B | $7.61B | $7.75B | $8.61B | -1.7% |
| Total current assets | $38.73B | $40.04B | $33.45B | $33.82B | -3.3% |
| Property, plant & equipment | $22.93B | $23.74B | $22.94B | $24.21B | -3.4% |
| Goodwill & intangibles | $26.81B | $25.18B | $24.22B | $20.50B | +6.5% |
| Total assets | $100.70B | $101.80B | $90.47B | $88.15B | -1.1% |
| Total current liabilities | $28.00B | $27.02B | $24.82B | $27.24B | +3.6% |
| Current debt | $4.21B | $3.93B | $4.40B | $3.96B | +7.0% |
| Long-term debt | $27.43B | $30.72B | $24.81B | $21.39B | -10.7% |
| Total debt | $33.19B | $36.35B | $30.78B | $26.54B | -8.7% |
| Total liabilities | $62.82B | $65.64B | $57.20B | $56.14B | -4.3% |
| Retained earnings | $48.84B | $43.84B | $42.35B | $38.94B | +11.4% |
| Shareholder equity | $33.80B | $31.77B | $29.32B | $27.99B | +6.4% |
| Working capital | $10.73B | $13.01B | $8.62B | $6.58B | -17.6% |
| Net tangible assets | $6.99B | $6.59B | $5.10B | $7.49B | +6.1% |
| Shares issued | 809.25M | 809.25M | 809.25M | 809.25M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $13.80B | $9.19B | $12.36B | $13.53B | — | +50.2% |
| Depreciation & amortisation | $3.39B | $3.42B | $3.46B | $3.84B | — | -1.1% |
| Stock-based compensation | $857.00M | $855.00M | $830.00M | $738.00M | — | +0.2% |
| Change in working capital | -$1.66B | $1.16B | -$1.11B | -$2.42B | — | -242.7% |
| Operating cash flow | $18.85B | $20.09B | $16.09B | $17.80B | — | -6.2% |
| Capital expenditure | -$5.78B | -$5.01B | -$4.65B | -$4.55B | — | -15.4% |
| Investing cash flow | -$8.54B | -$11.39B | -$10.64B | -$2.92B | — | +25.0% |
| Share buybacks | — | — | — | $0 | -$18.99B | — |
| Dividends paid | -$7.73B | -$7.65B | -$7.59B | -$7.45B | — | -1.1% |
| Financing cash flow | -$11.37B | -$6.82B | -$4.24B | -$16.27B | — | -66.7% |
| Free cash flow | $13.07B | $15.09B | $11.45B | $13.25B | — | -13.3% |
| End cash position | $5.58B | $6.97B | $5.38B | $4.99B | — | -20.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2026-06-30 | 2025-12-31 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $5.45B | $5.58B | — | $6.97B | -2.4% |
| Cash & short-term investments | $9.73B | $15.48B | $12.03B | $17.32B | -37.1% |
| Accounts receivable | $12.91B | $12.39B | $11.92B | $12.01B | +4.2% |
| Inventory | $8.09B | $7.48B | $7.60B | $7.61B | +8.2% |
| Total current assets | $35.44B | $38.73B | $35.70B | $40.04B | -8.5% |
| Property, plant & equipment | $23.41B | $22.93B | $22.87B | $23.74B | +2.1% |
| Goodwill & intangibles | $27.09B | $26.81B | $24.33B | $25.18B | +1.0% |
| Total assets | $98.20B | $100.70B | $94.77B | $101.80B | -2.5% |
| Total current liabilities | $28.85B | — | $27.58B | — | — |
| Current debt | $6.58B | $4.21B | — | $3.93B | +56.5% |
| Long-term debt | $25.22B | $27.43B | $26.46B | $30.72B | -8.0% |
| Total debt | $31.80B | $33.19B | — | $36.35B | -4.2% |
| Total liabilities | $61.48B | $62.82B | $61.72B | $65.64B | -2.1% |
| Retained earnings | $47.55B | $48.84B | — | $43.84B | -2.6% |
| Shareholder equity | $32.69B | $33.80B | $28.68B | $31.77B | -3.3% |
| Working capital | $6.59B | $10.73B | — | $13.01B | -38.6% |
| Net tangible assets | $5.60B | $6.99B | $4.35B | $6.59B | -19.8% |
| Shares issued | 809.25M | 809.25M | 809.25M | 809.25M | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $15.57B | +4.3% |
| Next quarter | — | — | $16.17B | +3.3% |
| Current year | — | — | $62.64B | +1.8% |
| Next year | — | — | $65.47B | +4.5% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.00%
Held by institutions0.53%
Institutions holding127
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
48.28
+0.52% from price
SMA 20
48.10
+0.89% from price
SMA 50
45.98
+5.56% from price
SMA 100
44.77
+8.39% from price
SMA 200
44.61
+8.80% from price
EMA 12
48.05
+1.00% from price
EMA 26
47.40
+2.39% from price
EMA 50
46.47
+4.42% from price
RSI (14)
57.0
Neutral
MACD (12,26,9)
0.66
Hist -0.09
ATR (14)
0.67
1.38% of price
Realised vol 30D
28.1%
Annualised
Bollinger upper
49.58
20, 2σ
Bollinger lower
46.63
20, 2σ
50 / 200 cross
Golden
45.98 vs 44.61
Trend bias
Above 200
+8.80%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.20
Less volatile than market
Correlation to SPY
-0.09
Largely independent
Realised vol 30D
28.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-19.1%
Peak to trough
Max drawdown 5Y
-43.2%
Peak to trough
ATR 14
0.67
1.38% of price
Beta (reported)
0.35
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 12, 23 | TD Cowen | MAINTAINED | Market Perform | Market Perform |
| Nov 15, 22 | Cowen & Co. | DOWNGRADE | Outperform | Market Perform |
| Jun 27, 22 | Cowen & Co. | MAINTAINED | — | Outperform |
| Jul 8, 21 | Deutsche Bank | UPGRADE | Hold | Buy |
| Jan 28, 19 | Argus Research | INITIATED | — | Buy |
| Jan 28, 19 | Credit Suisse | UPGRADE | Underperform | Neutral |
| Nov 19, 18 | Goldman Sachs | DOWNGRADE | Conviction Buy | Buy |
| May 25, 18 | Credit Suisse | DOWNGRADE | Neutral | Underperform |
| May 10, 18 | Bernstein | DOWNGRADE | Outperform | Market Perform |
| Jan 8, 15 | UBS | DOWNGRADE | Buy | Neutral |
| Mar 13, 14 | Morgan Stanley | INITIATED | — | Overweight |
| Aug 22, 12 | JP Morgan | UPGRADE | Neutral | Overweight |
Dividends & splits
Forward rate$1.32 / yr
Forward yield2.72%
5-year avg yield3.23%
Payout ratio64.69%
Ex-dividend dateMar 13, 2026
Next pay date—
Last split2:1
Split dateFeb 27, 2014
Headlines
Raphinha, Lopez hit braces as Barcelona trounce Elche
AFP · 13m ago
Amorim starts Serie A life with Milan win, Juve edge Frosinone
AFP · 16m ago
Lawsuit filed in Napali coast ‘doors-off’ helicopter tour crash
The Honolulu Star-Advertiser · 16m ago
Does Billionaire Bill Ackman Know Something Wall Street Doesn’t? He Invested in These 2 Stocks That Have Dropped 33% and 18% Over the Past Year
Motley Fool · 17m ago
Liquor industry struggles grow with another Chapter 7 filing
TheStreet · 19m ago
Media Advisory: Housing Announcement in Toronto
CNW Group · 22m ago
Dow Jones Futures Due With Market At Key Point; Nvidia, Tariffs, Warsh In Focus
Investor's Business Daily · 29m ago
Axsome Therapeutics Stock Is Up 16% Year to Date. Why Wall Street Thinks It Has Even More Room to Run
Motley Fool · 32m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.